Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

271
Body:Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to...
271
Clinical Trials01:16

Clinical Trials

10.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.9K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.8K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.8K
Clinical Trials: Overview01:11

Clinical Trials: Overview

5.1K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.1K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

488
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
488

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Indolent γδT-cell clone in Felty syndrome: a case report and literature review].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi·2026
Same author

[Rituximab combined with intensive immunochemotherapy for sporadic adult Burkitt lymphoma: efficacy and prognosis analyse].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi·2025
Same author

[Clinical characteristics and prognosis analysis in patients with bone marrow invasive follicular lymphoma].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi·2025
Same author

[Progress in risk stratification and treatment of high-risk smoldering multiple myeloma].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi·2025
Same author

Retraction Note: SAR650984 directly induces multiple myeloma cell death via lysosomal-associated and apoptotic pathways, which is further enhanced by pomalidomide.

Leukemia·2024
Same author

[The efficacy and safety of ibrutinib in the treatment of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi·2024
Same journal

Sodium-Glucose Cotransporter 2 Inhibitors as Discharge Medications in Survivors of Acute Myocardial Infarction Complicated by Cardiogenic Shock.

Shock (Augusta, Ga.)·2026
Same journal

Dynamic Temperature Modeling Predicts Mortality in Murine Sepsis.

Shock (Augusta, Ga.)·2026
Same journal

Changes of Intestinal Aquaporins after Experimental Polytrauma and Hemorrhagic Shock: Erratum.

Shock (Augusta, Ga.)·2026
Same journal

Effect of Chest Compression Release Velocity on Cerebral Perfusion Pressure in a Porcine Cardiac Arrest Model: Erratum.

Shock (Augusta, Ga.)·2026
Same journal

Ulinastatin Treatment Associated with Lower Sepsis-Associated Encephalopathy Risk in Sepsis Patients: A Multicenter Observational Study.

Shock (Augusta, Ga.)·2026
Same journal

Optimization of Preclinical Rodent Research Models of Human Shock: Part 2 Trauma, Burn, and the Gut Microbiome.

Shock (Augusta, Ga.)·2026
See all related articles

Related Experiment Video

Updated: Feb 17, 2026

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

1.6K

Agent-based computer simulation and sirs: building a bridge between basic science and clinical trials.

G An1

  • 1Department of Trauma, Cook County Hospital, Chicago, Illinois 60612, USA.

Shock (Augusta, Ga.)
|October 3, 2001
PubMed
Summary
This summary is machine-generated.

Systemic Inflammatory Response Syndrome (SIRS) and Multiple Organ Failure (MOF) management is challenging. Agent-Based Computer Simulation (ABCS) models the inflammatory process

More Related Videos

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.3K
Interactive and Visualized Online Experimentation System for Engineering Education and Research
08:35

Interactive and Visualized Online Experimentation System for Engineering Education and Research

Published on: November 24, 2021

3.0K

Related Experiment Videos

Last Updated: Feb 17, 2026

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

1.6K
In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.3K
Interactive and Visualized Online Experimentation System for Engineering Education and Research
08:35

Interactive and Visualized Online Experimentation System for Engineering Education and Research

Published on: November 24, 2021

3.0K

Area of Science:

  • Critical Care Medicine
  • Computational Biology
  • Systems Biology

Background:

  • Managing Systemic Inflammatory Response Syndrome (SIRS) and Multiple Organ Failure (MOF) is a significant challenge in critical care.
  • Translating basic science findings into effective therapies for SIRS/MOF has proven difficult, possibly due to overlooking the inflammatory process' complex, nonlinear dynamics.
  • Interventions without understanding system dynamics may lead to adverse outcomes.

Purpose of the Study:

  • To propose Agent-Based Computer Simulation (ABCS) as a method to model the complex, nonlinear nature of the inflammatory process.
  • To develop an abstracted, cellular-level ABCS of inflammation.
  • To demonstrate the potential of ABCS in bridging basic science discoveries and clinical applications.

Main Methods:

  • Construction of an abstracted Agent-Based Computer Simulation (ABCS) of the inflammatory process at the cellular level.
  • Analysis of the simulation's emergent nonlinear behavior and dynamic structure.
  • Modeling a specific unsuccessful anti-inflammatory clinical trial from the 1990s within the simulation.

Main Results:

  • The abstracted ABCS successfully reproduced nonlinear inflammatory dynamics and the overall response structure.
  • Simulating an unsuccessful anti-inflammatory trial replicated the observed adverse clinical outcomes.
  • The model, despite its abstraction, highlights the potential pitfalls of simplistic interventions.

Conclusions:

  • Agent-Based Computer Simulation (ABCS) offers a promising approach to model the complexity of inflammatory processes like SIRS/MOF.
  • ABCS can help understand why certain therapeutic strategies fail and guide future research.
  • Sophisticated ABCS models, developed through collaboration, could be crucial for translating basic science into clinical practice.